West Hollywood, CA, United States of America

Vincenzo Calvanese

This inventor holds 1 USPTO granted patent. Top assignee: The J. David Gladstone Institutes. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Vincenzo Calvanese

Introduction

Vincenzo Calvanese is an accomplished inventor based in West Hollywood, CA. He has made significant contributions to the field of biomedical research, particularly in the detection of latently-infected cells related to HIV.

Latest Patents

Calvanese holds a patent for a dual-color HIV reporter system designed for the detection of latently-infected cells. This innovative system includes recombinant nucleic acids and cells that can identify, isolate, and purify cells latently infected with the immunodeficiency virus. The patent outlines a recombinant nucleic acid that comprises a first nucleotide sequence encoding a first reporter polypeptide, which produces a detectable signal linked to an immunodeficiency virus promoter. Additionally, it includes a second nucleotide sequence that encodes a second reporter polypeptide, producing a distinguishable signal linked to a non-immunodeficiency virus promoter. This dual-color system enhances the ability to study and understand HIV latency.

Career Highlights

Calvanese is associated with the J. David Gladstone Institutes, where he conducts his research. His work focuses on innovative solutions to complex biomedical challenges, particularly in the realm of viral infections.

Collaborations

One of his notable collaborators is Eric M. Verdin, with whom he has worked on various research projects aimed at advancing the understanding of HIV and its effects.

Conclusion

Vincenzo Calvanese's contributions to HIV research through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…